Information:
Fel:
ID
16732
Beskrivning
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193167
Länk
https://clinicaltrials.gov/show/NCT00193167
Nyckelord
Versioner (1)
- 2016-08-03 2016-08-03 -
Uppladdad den
3 augusti 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Colon Cancer NCT00193167
Eligibility Colon Cancer NCT00193167
- StudyEvent: Eligibility
Similar models
Eligibility Colon Cancer NCT00193167
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
criteria Fulfill
Item
to be included in this study, you must meet the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Colorectal cancer metastatic
Item
metastatic colorectal cancer
boolean
C0948380 (UMLS CUI [1])
Prior Chemotherapy Quantity Neoplasm Metastasis
Item
one previous chemotherapy for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
C1516986 (UMLS CUI [2])
Performance of activities of daily living Assisted Ability
Item
able to perform activities of daily living with assistance
boolean
C1821398 (UMLS CUI [1,1])
C1269765 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C1269765 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver, and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed consent
Item
all patients must give written informed consent prior to study entry.
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status
Item
you cannot participate in this study if any of the following apply to you:
boolean
C2348568 (UMLS CUI [1])
Brain Involvement | Meninges Involvement
Item
brain or meningeal involvement
boolean
C0006104 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0025285 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C1314939 (UMLS CUI [1,2])
C0025285 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
Communicable Diseases Serious | medical condition Serious
Item
serious active infection or underlying medical conditions
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Neoplasms
Item
other active neoplasms are ineligible
boolean
C0027651 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C2348568 (UMLS CUI [1])